论文部分内容阅读
目前临床上有许多治疗脑供血不足的药物,但有些药物效果不佳,有些药物副作用较明显,患者不易接受。尼莫地平是双氢钙通道阻滞剂,脂溶性大,容易通过血脑屏障,增强扩张脑血管作用,从而增加脑供血量。它不仅能解除由脑血管神经功能失调引起的单纯性脑血管痉挛,而对脑动脉硬化增厚变硬的血管壁亦有松弛降低张力作用,因而增加了脑血流量.保护脑细胞功能,阻止病情进展.尼莫地平副作用轻微.适合长期用药。本文治疗12例脑供血不足患者.效果满意,现报告如下。
Currently there are many clinical treatment of brain blood shortage of drugs, but some poor drug effect, some obvious side effects of drugs, the patient is not easy to accept. Nimodipine is a dihydrogen calcium channel blocker, fat-soluble, easy to cross the blood-brain barrier and enhance the role of cerebral vasoconstriction, thereby increasing cerebral blood supply. It can not only relieve the simple cerebral vasospasm caused by cerebrovascular neurological dysfunction, but also relax and reduce the tension on the hardened blood vessel wall of cerebral arteriosclerosis, thereby increasing the cerebral blood flow, protecting the function of brain cells, preventing Nimodipine mild side effects. For long-term medication. This article treats 12 patients with cerebral insufficiency, the results are satisfactory, are as follows.